Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
Featured Topics
FDA Monkeypox Response
The FDA’s multipronged response to monkeypox includes efforts in the areas of diagnostics, vaccines and therapeutics.
Infant Formula Information and Resources
The FDA continues to work around the clock with our government partners and industry to ensure there's adequate infant formula available wherever and whenever parents and caregivers need it.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Sep 24
TreeHouse Foods Announces Voluntary Recall of Certain Tuscan Garden Restaurant Style Italian Dressing Due to Undeclared Wheat and Soy
Food & Beverages
Sep 23
Van Law Food Products Issues Allergy Alert on Undeclared Soy and Wheat in Product Expanded
Food & Beverages
Sep 23
Arcade Snacks Issues Allergy Alert on Undeclared Egg in Candy Corn
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Issues New Guidance to Help Facilitate Availability of Naloxone to Prevent Opioid Overdoses and Reduce Death
The FDA is building on our actions by helping facilitate the availability and access to this life saving medication.
Using A Whole-Of-Governments Approach to Combating Illicit Health Products
A whole-of-governments approach is the best way to protect the public health from the trade of illicit health products.
FDA’s Overdose Prevention Framework Aims to Prevent Drug Overdoses and Reduce Death
The FDA Overdose Prevention Framework is our vision to undertake impactful, creative actions to prevent drug overdoses and reduce deaths.
Recently Published Guidances
Sep 26
Ethical Considerations for Clinical Investigations of Medical Products Involving Children
Biologics, Drugs, Medical Devices
Sep 22
Exemption and Exclusion From Certain Requirements of the Drug Supply Chain Security Act for the Distribution of FDA-Approved Naloxone Products During the Opioid Public Health Emergency Guidance for Industry
Drugs
Sep 22
Electronic Submission Template for Medical Device 510(k) Submissions
Biologics, Medical Devices